ADRs leading to discontinuation occurred in 13.4% of patients and included leukopenia and neutropenia (4.3% for each), peripheral neuropathy (1.2%), and febrile neutropenia, lymphopenia, malaise, C-reactive protein increased, and hemoglobin decreased (0.8% for each). The gene discussed is CRP; the disease is neutropenia.